Skip to content

A study on the efficacy of aschyotana with Bilwadi kwath and Shigrupatra swarasa in the management of Allergic Conjunctivitis

Comparative clinical study to evaluate the effect of Aschyotana with Bilwadi Kwath and Shigrupatra Swarasa in Vataja Abhishyanda(Allergic Conjunctivitis) - NIL

Status
Active, not recruiting
Phases
Phase 2
Study type
Interventional
Source
CTRI
Registry ID
CTRI/2026/07/113644
Enrollment
60
Registered
2026-07-07
Start date
Unknown
Completion date
Unknown
Last updated
2026-08-03

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Health Condition 1: H108- Other conjunctivitis

Interventions

None listed

Sponsors

Patanjali bhartiya ayurvigyan avum anusandhan sansthan haridwar
Lead Sponsor

Eligibility

Inclusion criteria

Inclusion criteria: Subjects with classical symptoms of vataja abhishyanda Subjects within the age of 6 to 50 years of both gender Patient willing to participate in this trial

Exclusion criteria

Exclusion criteria: Subjects with complications like corneal involvement like marginal corneal ulcer etc Patients with ocular surgery or trauma within 3 months, LASIK within 6 months Patients suffering from systemic disease and metabolic disorders

Design outcomes

Primary

MeasureTime frame
pricking pain foreign body sensation watery discharge feeling of dryness headache itching oedema of lidsTimepoint: 0,44,59 days

Secondary

MeasureTime frame
AEC hyperemia conjunctival redness by Efron grading scale visual acuity by logMARTimepoint: 0,44,59 days

Countries

India

Contacts

Public ContactRiya Singh

Patanjali Bhartiya Ayurvigyan Evam Anusandhan Sansthan

arunpandey.pandey@gmail.com8859761559

Outcome results

None listed

Source: CTRI (via WHO ICTRP) · Data processed: Aug 10, 2026